In the last trading session, 1.68 million shares of the Tandem Diabetes Care Inc (NASDAQ:TNDM) were traded, and its beta was 1.12. Most recently the company’s share price was $35.41, and it changed around $0.11 or 0.31% from the last close, which brings the market valuation of the company to $2.32B. TNDM currently trades at a discount to its 52-week high of $43.51, offering almost -22.87% off that amount. The share price’s 52-week low was $13.82, which indicates that the current value has risen by an impressive 60.97% since then. We note from Tandem Diabetes Care Inc’s average daily trading volume that its 10-day average is 1.82 million shares, with the 3-month average coming to 1.85 million.
Tandem Diabetes Care Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.11. If we narrow it down even further, the data shows that 1 out of 18 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 9 recommended TNDM as a Hold, whereas 6 deemed it a Buy, and 0 rated it as Underweight. Tandem Diabetes Care Inc is expected to report earnings per share of -$0.75 for the current quarter.
Tandem Diabetes Care Inc (NASDAQ:TNDM) trade information
Instantly TNDM has showed a green trend with a performance of 0.31% at the end of last trading. The performance over the last five days has remained in the green territory. The company’s shares are currently up 19.71% year-to-date, but still up 11.14% over the last five days. On the other hand, Tandem Diabetes Care Inc (NASDAQ:TNDM) is 33.22% up in the 30-day period. We can see from the shorts that 8.08 million shares have been sold at a short interest cover period of 3.09 day(s).
The consensus price target as assigned by Wall Street analysts is $109.89, which translates to bulls needing to increase their stock price by 67.78% from its current value. Analyst projections state that TNDM is forecast to be at a low of $37 and a high of $160.
Tandem Diabetes Care Inc (TNDM) estimates and forecasts
Tandem Diabetes Care Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 70.16 percent over the past six months and at a -3.18% annual growth rate that is well below the industry average of 13.60%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will loss -19.00% in revenue this quarter, and will report a decrease of -70.00% in the next quarter. The year-over-year growth rate is expected to be 13.00%, up from the previous year.
Consensus estimates provided by 16 financial analysts predict the company will bring in an average of $174.25 million in revenue for the current quarter. 16 analysts expect Tandem Diabetes Care Inc to make $204.55 million in revenue for the quarter ending Jun 2024. The company’s sales for the same quarters a year ago were $170.23 million and $197.36 million respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 2.40%. Forecasts for the next quarter put sales growth at 3.60%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -6.11%.
TNDM Dividends
Tandem Diabetes Care Inc’s next quarterly earnings report is expected to be released around May 01 and May 06.
Tandem Diabetes Care Inc (NASDAQ:TNDM)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.64% of Tandem Diabetes Care Inc shares, and 110.27% of them are in the hands of institutional investors. The stock currently has a share float of 110.98%. Tandem Diabetes Care Inc stock is held by 381 institutions, with Blackrock Inc. being the largest institutional investor. By Jun 29, 2023, it held 13.78% of the shares, which is about 8.97 million shares worth $220.13 million.
Vanguard Group Inc, with 10.78% or 7.01 million shares worth $172.1 million as of Jun 29, 2023, holds the second largest percentage of outstanding shares.
Smallcap World Fund and iShares Core S&P Smallcap ETF were the top two Mutual Funds as of Jun 29, 2023. The former held 4.53 million shares worth $111.05 million, making up 6.95% of all outstanding shares. On the other hand, iShares Core S&P Smallcap ETF held roughly 4.39 million shares worth around $91.26 million, which represents about 6.75% of the total shares outstanding.
